ExpertiseUpdated on 10 April 2026
Bioprocess Technology Evaluation & Integration for ATMP
About
The rapid evolution of bioproduction technologies (automation systems, closed systems, analytical tools) creates strong opportunities but also challenges in demonstrating their value within real ATMP workflows.
As part of the Établissement Français du Sang (EFS), we offer a unique environment combining expertise in cell therapies, access to biological materials and hands-on process development capabilities.
Through our biotherapy innovation hub, we support technology providers in assessing and positioning their solutions within bioproduction processes.
Our activities include:
• Technology evaluation and benchmarking within relevant ATMP workflows
• Integration into existing or emerging bioprocesses
• Performance assessment (robustness, scalability, reproducibility)
• Generation of data to support industrial and clinical adoption
We collaborate with equipment and technology providers to accelerate the validation and adoption of innovative solutions in the cell and gene therapy field.
Field
- Biotech, Pharma and Cosmetics
Organisation
Similar opportunities
Expertise
ATMP Process Development & Bioproduction Maturation
- Biotech, Pharma and Cosmetics
Angèle Boyard
Business developer bioproduction at EFS BFC
Besançon, France
Project cooperation
Bringing Cell Analysis to an Upper Dimension for Bioproduction & CGT
- Early
- Planning
- Research
- Execution
- Technical
- Healthcare
- EU projects
- Biotech, Pharma and Cosmetics
- Partner looking for consortium
- Food, Beverages and Agriculture
- Coordinator looking for partners
Andrei Constantinescu
Founder and CEO - HemaVision at HemaVision
Dijon, France
Partnership
Bringing Cell Analysis to an Upper Dimension for Bioproduction & CGT
Andrei Constantinescu
Founder and CEO - HemaVision at HemaVision
Dijon, France